Rapid Micro Biosystems Inc. (RPID): רווח נקי למניה (EPS TTM)
Rapid Micro Biosystems (RPID) is developing a high-margin supply model for consumable cassettes, with revenue based on the sale of diagnostic robots and ancillary materials. Technological superiority is driven by the Growth Direct autonomous laser colony counting system. The trailing twelve-month net income per share on the GURU.Markets daily price chart shows that the current value is -1.11, helping investors rebalance capital in a timely manner.
פילוחים אנליטיים ודוחות נתונים של חברת Rapid Micro Biosystems Inc. (RPID)
The investment attractiveness of Rapid Micro Biosystems (RPID) depends on its ability to monetize synergies with pharmaceutical behemoths during the implementation of Growth Direct systems. This metric reflects the net profit per share annually, allowing for an assessment of real business efficiency relative to the total shares outstanding. By analyzing this chart of net profit per share over the last 12 months, an investor can determine the stage of capital growth or the risks of yield volatility.
